Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on oral RP3128 showing safety, tolerability, and pharmacokinetics in healthy volunteers and asthma patients; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RP3128 (RP3128)

Snippet

Sponsor: Rhizen Pharmaceuticals SA | Conditions: Healthy Volunteers, Asthma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-10-04